In: Journal of Materials Science: Materials in Medicine, 2015, vol. 26, no. 3, p. 1-8
|
In: Journal of Antimicrobial Chemotherapy, 2017, vol. 72, no. 4, p. 1089-1093
|
In: Journal of Antimicrobial Chemotherapy, 2016, vol. 71, no. 1, p. 141-151
|
In: International Orthopaedics, 2015, vol. 39, no. 3, p. 397-401
|
In: Journal of Antimicrobial Chemotherapy, 2017, vol. 72, no. 2, p. 444-447
|
In: The Journal of Infectious Diseases, 2016, vol. 213, no. 9, p. 1370-1379
|
In: European Journal of Pediatrics, 2015, vol. 174, no. 9, p. 1255-1262
|
In: European Journal of Medicinal Chemistry, 2020, vol. 205, p. 112533
We have prepared a series of ten 3-arylcoumarin molecules, their respective fac- [Re(CO)3(bpy)L]+ and fac-[Re(CO)3(L⁀L)Br] complexes and tested all compounds for their antimicrobial efficacy. Whereas the 3-arylcoumarin ligands are virtually inactive against the human-associated pathogens with minimum inhibitory concentrations (MICs) > 150 μM, when coordinated to the fac-[Re(CO)3]+ core,...
|
In: European Journal of Clinical Microbiology & Infectious Diseases, 2014, vol. 33, no. 11, p. 1967-1971
|
In: Infection, 2014, vol. 42, no. 3, p. 511-519
|